Reardon Andrew

CLO & Secretary

Reardon Andrew has filed 10 SEC Form 4 filings (76 transaction rows) across 1 company, with disclosures dating back to 2026. 10 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.

On the most recent filing, Reardon Andrew is listed as CLO & Secretary at LIGAND PHARMACEUTICALS INC. Inside the rolling window, Reardon Andrew reported no open-market purchases and 8 open-market sales totaling $10.3M in LGND. The largest disclosed transaction in the window is a sale of 5,000 LGND shares on Jul 1, 2026, worth $1.6M.

Companies traded

Other insiders at LGND

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$10.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LGNDSale$1.5MOct 6SEC ↗
LGNDSale$1.4MSep 8SEC ↗
LGNDSale$1.4MAug 4SEC ↗
LGNDSale$1.6MJul 6SEC ↗
LGNDSale$1.1MJun 2SEC ↗
LGNDSale$1.2MMay 5SEC ↗
LGNDSale$1.0MApr 2SEC ↗
LGNDSale$1.0MMar 6SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Reardon Andrew made?

Reardon Andrew has filed 10 SEC Form 4 filings (76 transaction rows) across 1 company since 2026.

Which companies does Reardon Andrew trade?

Reardon Andrew has filed SEC Form 4 disclosures for 1 company, including LGND.

When was Reardon Andrew's most recent SEC Form 4 filing?

Reardon Andrew's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.

What is Reardon Andrew's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Reardon Andrew is listed as CLO & Secretary.

What is Reardon Andrew's total buy and sell value in the current window?

Inside the rolling retention window, Reardon Andrew bought $0 and sold $10.3M based on SEC Form 4 filings.

What was Reardon Andrew's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,000 LGND shares on 2026-07-01, worth $1.6M, per SEC Form 4 filings.